Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up.

Langston ME, Pakpahan R, Nevin RL, De Marzo AM, Elliott DJ, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Zenilman JM, Platz EA, Sutcliffe S.

Prostate. 2018 Sep;78(13):1024-1034. doi: 10.1002/pros.23660. Epub 2018 May 30.

PMID:
30133756
2.

Considerations in the repurposing of mefloquine for prevention and treatment of osteoporosis.

Nevin RL.

Bone. 2018 Sep;114:304-305. doi: 10.1016/j.bone.2018.06.025. Epub 2018 Jul 4. No abstract available.

PMID:
30037669
3.

Measurement of Mefloquine Exposure in Studies of Veterans' Sleep Disorders.

Nevin RL.

J Clin Sleep Med. 2018 Jul 15;14(7):1273-1274. doi: 10.5664/jcsm.7250. No abstract available.

4.
5.

Mefloquine Exposure May Confound Associations and Limit Inference in Military Studies of Posttraumatic Stress Disorder.

Nevin RL.

Mil Med. 2017 Nov;182(11):1757. doi: 10.7205/MILMED-D-17-00287. No abstract available.

PMID:
29087843
6.

Implications of Changes to the Mefloquine Product Monograph.

Nevin RL.

Can J Hosp Pharm. 2017 Jul-Aug;70(4):323-324. Epub 2017 Aug 31. No abstract available.

7.

Association of Poultry Processing Industry Exposures With Reports of Occupational Finger Amputations: Results of an Analysis of OSHA Severe Injury Report (SIR) Data.

Nevin RL, Bernt J, Hodgson M.

J Occup Environ Med. 2017 Oct;59(10):e159-e163. doi: 10.1097/JOM.0000000000001135.

PMID:
28820861
8.
9.

Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.

Milbrandt M, Winter AC, Nevin RL, Pakpahan R, Bradwin G, De Marzo AM, Elliott DJ, Gaydos CA, Isaacs WB, Nelson WG, Rifai N, Sokoll LJ, Zenilman JM, Platz EA, Sutcliffe S.

Prostate. 2017 May;77(13):1325-1334. doi: 10.1002/pros.23392. Epub 2017 Jul 12.

10.

Confounding by Symptomatic Mefloquine Exposure in Military Studies of Post-Traumatic Stress Disorder.

Nevin RL.

Behav Med. 2018 Apr-Jun;44(2):171-172. doi: 10.1080/08964289.2017.1330248. Epub 2017 Jun 12. No abstract available.

PMID:
28506155
11.
12.
13.

Stellate Ganglion Block in the Treatment of Post-traumatic Stress Disorder: A Review of Historical and Recent Literature.

Summers MR, Nevin RL.

Pain Pract. 2017 Apr;17(4):546-553. doi: 10.1111/papr.12503. Epub 2016 Oct 14. Review.

PMID:
27739175
14.

The timeliness of the US military response to the 2014 Ebola disaster: a critical review.

Nevin RL, Anderson JN.

Med Confl Surviv. 2016 Jan-Mar;32(1):40-69. doi: 10.1080/13623699.2016.1212491. Epub 2016 Jul 25.

PMID:
27454885
15.

Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives.

Nevin RL, Croft AM.

Malar J. 2016 Jun 22;15:332. doi: 10.1186/s12936-016-1391-6. Review.

16.

Considerations in the Repositioning of Mefloquine for Anesthetic Indications.

Nevin RL.

Anesthesiology. 2016 Jul;125(1):253-4. doi: 10.1097/ALN.0000000000001138. No abstract available.

PMID:
27326498
17.
18.

Prohibiting direct medical care by US military personnel in foreign disaster relief: arguments from the Ebola disaster.

Anderson JN, Nevin RL.

Med Confl Surviv. 2016 Jan-Mar;32(1):14-20. doi: 10.1080/13623699.2016.1185683. Epub 2016 May 19. No abstract available.

PMID:
27198558
19.

Bias in military studies of mefloquine.

Nevin RL.

J Travel Med. 2016 Feb 1;23(2):tav028. doi: 10.1093/jtm/tav028. Print 2016 Feb. No abstract available.

PMID:
26849885
20.

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection.

Sutcliffe S, Nevin RL, Pakpahan R, Elliott DJ, Langston ME, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Walsh PC, Zenilman JM, Cersovsky SB, Platz EA.

Int J Cancer. 2016 May 1;138(9):2221-30. doi: 10.1002/ijc.29966. Epub 2016 Jan 21.

21.

Rational Risk-Benefit Decision-Making in the Setting of Military Mefloquine Policy.

Nevin RL.

J Parasitol Res. 2015;2015:260106. doi: 10.1155/2015/260106. Epub 2015 Oct 22. Review.

22.

Unexpected pharmacological and toxicological effects of tafenoquine.

Nevin RL.

Occup Med (Lond). 2015 Jul;65(5):417. doi: 10.1093/occmed/kqv049. No abstract available.

PMID:
26187807
23.

Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy.

Maxwell NM, Nevin RL, Stahl S, Block J, Shugarts S, Wu AH, Dominy S, Solano-Blanco MA, Kappelman-Culver S, Lee-Messer C, Maldonado J, Maxwell AJ.

Clin Case Rep. 2015 Jun;3(6):379-87. doi: 10.1002/ccr3.238. Epub 2015 Apr 9.

24.

Organic depersonalization as a chronic sequela of mefloquine intoxication.

Nevin RL.

Psychosomatics. 2015 Jan-Feb;56(1):103. doi: 10.1016/j.psym.2014.08.005. Epub 2014 Aug 27. No abstract available.

PMID:
25619679
25.

Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.

Nevin RL.

Int J Parasitol Drugs Drug Resist. 2014 Apr 5;4(2):118-25. doi: 10.1016/j.ijpddr.2014.03.002. eCollection 2014 Aug.

26.

Population estimates of undocumented incident traumatic brain injuries among combat-deployed US military personnel.

Chase RP, Nevin RL.

J Head Trauma Rehabil. 2015 Jan-Feb;30(1):E57-64. doi: 10.1097/HTR.0000000000000061. Erratum in: J Head Trauma Rehabil. 2015 Mar-Apr;30(2):69-74.

PMID:
24810487
27.

Suicides among military personnel.

Nevin RL, Ritchie EC.

JAMA. 2013 Dec 18;310(23):2563-4. doi: 10.1001/jama.2013.282692. No abstract available.

PMID:
24346994
28.

Outbreak of H3N2 influenza at a US military base in Djibouti during the H1N1 pandemic of 2009.

Cosby MT, Pimentel G, Nevin RL, Fouad Ahmed S, Klena JD, Amir E, Younan M, Browning R, Sebeny PJ.

PLoS One. 2013 Dec 5;8(12):e82089. doi: 10.1371/journal.pone.0082089. eCollection 2013.

29.

Re: McGuire JM. The incidence of and risk factors for emergence delirium in U.S. military combat veterans. Journal of Perianesthesia Nursing. 2012;27(4):236-45.

Nevin RL.

J Perianesth Nurs. 2013 Dec;28(6):334-5. doi: 10.1016/j.jopan.2013.09.003. No abstract available.

PMID:
24267619
30.

Letter to the editor.

Nevin RL, Caci J.

MSMR. 2013 Aug;20(8):24. No abstract available.

PMID:
24011374
31.

Psychiatric side effects of mefloquine: applications to forensic psychiatry.

Ritchie EC, Block J, Nevin RL.

J Am Acad Psychiatry Law. 2013;41(2):224-35.

PMID:
23771936
32.

Falling rates of malaria among U.S. military service members in Afghanistan substantiate findings of high compliance with daily chemoprophylaxis.

Nevin RL.

Am J Trop Med Hyg. 2012 Nov;87(5):957-8; author reply 959. doi: 10.4269/ajtmh.2012.12-0277a. No abstract available.

33.

Neuropharmacokinetic heterogeneity of mefloquine in the treatment of progressive multifocal leukoencephalopathy.

Nevin RL.

Intern Med. 2012;51(16):2257; author reply 2259. Epub 2012 Aug 15. No abstract available.

34.

Mass administration of the antimalarial drug mefloquine to Guantánamo detainees: a critical analysis.

Nevin RL.

Trop Med Int Health. 2012 Oct;17(10):1281-8. doi: 10.1111/j.1365-3156.2012.03063.x. Epub 2012 Aug 12.

35.

Mefloquine gap junction blockade and risk of pregnancy loss.

Nevin RL.

Biol Reprod. 2012 Sep 21;87(3):65. Print 2012 Sep. Review.

PMID:
22837476
36.

Limitations of postmarketing surveillance in the analysis of risk of pregnancy loss associated with maternal mefloquine exposure.

Nevin RL.

Clin Infect Dis. 2012 Oct;55(8):1167-8; author reply 1168-9. Epub 2012 Jul 3. No abstract available.

PMID:
22761410
37.

Prostate-specific antigen concentration in young men: new estimates and review of the literature.

Sutcliffe S, Pakpahan R, Sokoll LJ, Elliott DJ, Nevin RL, Cersovsky SB, Walsh PC, Platz EA.

BJU Int. 2012 Dec;110(11):1627-35. doi: 10.1111/j.1464-410X.2012.11111.x. Epub 2012 Apr 13. Review.

38.

Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report.

Nevin RL.

Travel Med Infect Dis. 2012 May;10(3):144-51. doi: 10.1016/j.tmaid.2012.03.006. Epub 2012 Apr 9.

PMID:
22494697
39.

Pharmacokinetic considerations in the repositioning of mefloquine for treatment of progressive multifocal leukoencephalopathy.

Nevin RL.

Clin Neurol Neurosurg. 2012 Oct;114(8):1204-5. doi: 10.1016/j.clineuro.2012.02.046. Epub 2012 Mar 14. No abstract available.

PMID:
22421250
40.

Investigating channel blockers for the treatment of multiple sclerosis: considerations with mefloquine and carbenoxolone.

Nevin RL.

J Neuroimmunol. 2012 Feb 29;243(1-2):106-7. doi: 10.1016/j.jneuroim.2011.12.016. Epub 2012 Jan 10. No abstract available.

PMID:
22236373
41.

Confounding and bias in studies of DMSS vaccination data.

Nevin RL.

Vaccine. 2012 Nov 26;30(50):7146. doi: 10.1016/j.vaccine.2011.12.100. Epub 2012 Jan 5. No abstract available.

PMID:
22226860
42.

Biased measurement of neuropsychiatric adverse effects of pediatric mefloquine treatment.

Nevin RL.

Pediatr Infect Dis J. 2012 Jan;31(1):102; author reply 102-3. doi: 10.1097/INF.0b013e31822fb178. No abstract available.

PMID:
22217970
43.

Hallucinations and persecutory delusions in mefloquine-associated suicide.

Nevin RL.

Am J Forensic Med Pathol. 2012 Jun;33(2):e8. doi: 10.1097/PAF.0b013e31823a8caf. No abstract available.

PMID:
22104331
44.

Serosurvey of bacterial and viral respiratory pathogens among deployed U.S. service members.

Eick AA, Faix DJ, Tobler SK, Nevin RL, Lindler LE, Hu Z, Sanchez JL, MacIntosh VH, Russell KL, Gaydos JC.

Am J Prev Med. 2011 Dec;41(6):573-80. doi: 10.1016/j.amepre.2011.08.006.

PMID:
22099233
45.

Malaria in the Republic of Djibouti, 1998-2009.

Ollivier L, Nevin RL, Darar HY, Bougère J, Saleh M, Gidenne S, Maslin J, Anders D, Decam C, Todesco A, Khaireh BA, Ahmed AA.

Am J Trop Med Hyg. 2011 Sep;85(3):554-9. doi: 10.4269/ajtmh.2011.11-0122.

46.

Mefloquine blockade of connexin 36 and connexin 43 gap junctions and risk of suicide.

Nevin RL.

Biol Psychiatry. 2012 Jan 1;71(1):e1-2. doi: 10.1016/j.biopsych.2011.07.026. Epub 2011 Sep 8. No abstract available.

PMID:
21861987
47.

Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration.

Sutcliffe S, Nevin RL, Pakpahan R, Elliott DJ, Cole SR, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Zenilman JM, Cersovsky SB, Platz EA.

Br J Cancer. 2011 Aug 23;105(5):602-5. doi: 10.1038/bjc.2011.271. Epub 2011 Jul 26.

48.

MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohort.

Scher AI, Wu H, Tsao JW, Blom HJ, Feit P, Nevin RL, Schwab KA.

J Neurotrauma. 2011 Sep;28(9):1739-45. doi: 10.1089/neu.2011.1982. Epub 2011 Sep 6.

PMID:
21787169
49.

Mefloquine blockade of connexin 43 (Cx43) and risk of pregnancy loss.

Nevin RL.

Placenta. 2011 Sep;32(9):712. doi: 10.1016/j.placenta.2011.06.016. Epub 2011 Jul 18. No abstract available.

PMID:
21764445
50.

Mental health standards for combat deployment.

Nevin RL.

Psychiatr Serv. 2011 Jul;62(7):805; author reply 805-6. doi: 10.1176/ps.62.7.pss6207_0805a. No abstract available.

PMID:
21724800

Supplemental Content

Loading ...
Support Center